Cyteir Therapeutics, Inc.
NASDAQ:CYT
3.02 (USD) • At close March 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -46.061 | -42.126 | -20.823 | -15.044 |
| Depreciation & Amortization
| 0.668 | 0.479 | 0.351 | 0.215 |
| Deferred Income Tax
| 0 | -4.423 | -0.142 | 0 |
| Stock Based Compensation
| 4.682 | 3.465 | 0.467 | 0.247 |
| Change In Working Capital
| -2.528 | 2.15 | 1.466 | -2.16 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.657 | 0.038 | 1.027 | -0.884 |
| Other Working Capital
| -1.871 | 2.112 | 0.439 | -1.276 |
| Other Non Cash Items
| 0.707 | 4.423 | 0.142 | -0.815 |
| Operating Cash Flow
| -42.532 | -36.032 | -18.539 | -17.557 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.312 | -1.189 | -0.85 | -0.133 |
| Acquisitions Net
| 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.312 | -1.189 | -0.85 | -0.133 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.064 | 0 | 1.427 | 36.89 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.242 | 216.006 | 1.427 | 36.89 |
| Financing Cash Flow
| 0.242 | 0.216 | 1.427 | 36.89 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
| Net Change In Cash
| -42.602 | 178.785 | -17.962 | 19.2 |
| Cash At End Of Period
| 147.377 | 189.979 | 11.194 | 29.156 |